亚太心律失常监测设备市场 - 增长、趋势、COVID-19 影响和预测(2022 - 2027 年)

亚太地区心律失常监测设备市场按设备(事件监测设备、连续心律监测设备、Holter 监测设备和其他设备)、服务提供商和地理位置进行细分。

市场快照

Market Snapshot1
Study Period: 2018 - 2026
Base Year: 2021
CAGR: 4.5 %

Need a report that reflects how COVID-19 has impacted this market and its growth?

市场概况

预计亚太地区心律失常监测设备市场在预测期内的复合年增长率将接近 4.5%。在大多数心脏疾病中,需要持续的心脏监测。虽然心律失常不能完全治愈,但持续监测心律失常患者的最佳方法是通过远程患者监测,即使用心律失常监测设备,即所谓的远程心脏病学。

日本是世界上人口老龄化速度最快的国家。根据 2019 年世界老龄化报告,估计 2019 年日本 65 岁以上的人口数量为 3552.4 万(28%),预计到 2030 年将达到 3727.8 万(30.9%)。预计未来几年老年人口将增加,他们更容易患心血管疾病等慢性疾病,这最终推动了市场的增长,因为这些人群需要对心脏进行监测,这最终会在不久的将来增加对监测设备的使用。

亚太地区心脏病发病率的上升也影响着医疗服务提供商实施先进的远程医疗服务。因此,预计远程心脏病学使用的增加将推动未来研究的市场。

Scope of the report

As per the scope of the report, Cardiac arrhythmia monitoring devices are used for monitoring the patients at risk or with heart arrhythmia. These devices detect and alarm the heartbeats that are irregular being either too slow or too fast. The Asia-Pacific Cardiac Arrhythmia Monitoring Devices Market is segmented by devices, service provider, and geography.

By Device
Event Monitoring Devices
Continuous Rhythm Monitoring Devices
Holter Monitoring Devices
Other Devices
By Service Provider
Mobile Cardiac Telemetry Monitoring Service Providers
Independent Diagnostic Testing Facilities/Clinics
Geography
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific

Report scope can be customized per your requirements. Click here.

主要市场趋势

动态心电图监测设备部分预计将主导亚太心律失常监测设备市场

动态心电图监测设备在市场上占主导地位,因为这些设备可以使用更长的时间来诊断受苦患者的散发症状。它们还提供更快、更方便的监测,以提高患者的依从性,并且还可能提高治疗效果。此外,心律失常监测设备市场出现了几项进步,这些进步正在迅速增加,这反过来又推动了心律失常监测设备市场的发展。

根据联合国人口基金 (UNFPA) 2017 年报告,据估计,到 2050 年,印度老年人的心脏病病例数预计将达到 1910 万,这将增加心脏监测设备的使用,这显示出积极的未来几年对市场的影响。

因此,随着心脏病的数量预计在不久的将来会增加,心律失常的患病率也预计会增加。这将增加对 Holter 监测设备的需求,这将对市场增长产生积极影响。

APAC cardiac key trend 3.png

竞争格局

亚太地区心律失常监测设备市场竞争激烈,主要参与者寥寥无几。拥有更多研究资金和更好分销体系的市场主体已经确立了自己的市场地位。此外,由于意识的提高,亚太地区正在出现一些小型企业,这也有助于市场增长。

Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Assumptions

    2. 1.2 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Increasing Use of Telecardiology

      2. 4.2.2 Development of Smart Cardiac Monitors

      3. 4.2.3 Ease of Use and Portability of Cardiac Arrhythmia Monitoring Devices

    3. 4.3 Market Restraints

      1. 4.3.1 High Cost of Remote Cardiac Arrhythmia Monitoring

    4. 4.4 Porter's Five Force Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION

    1. 5.1 By Device

      1. 5.1.1 Event Monitoring Devices

      2. 5.1.2 Continuous Rhythm Monitoring Devices

      3. 5.1.3 Holter Monitoring Devices

      4. 5.1.4 Other Devices

    2. 5.2 By Service Provider

      1. 5.2.1 Mobile Cardiac Telemetry Monitoring Service Providers

      2. 5.2.2 Independent Diagnostic Testing Facilities/Clinics

    3. 5.3 Geography

      1. 5.3.1 Asia-Pacific

        1. 5.3.1.1 China

        2. 5.3.1.2 Japan

        3. 5.3.1.3 India

        4. 5.3.1.4 Australia

        5. 5.3.1.5 South Korea

        6. 5.3.1.6 Rest of Asia-Pacific

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Company Profiles

      1. 6.1.1 Abbott Laboratories

      2. 6.1.2 Biotronik

      3. 6.1.3 GE Healthcare

      4. 6.1.4 Medtronic PLC

      5. 6.1.5 Koninklijke Philips NV

      6. 6.1.6 AliveCor Inc

      7. 6.1.7 iRhythm Technologies Inc

      8. 6.1.8 Medi-Lynx

    2. *List Not Exhaustive
  7. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Competitive Landscape covers- Business Overview, Financials, Products and Strategies, and Recent Developments

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The Asia-Pacific Cardiac Arrhythmia Monitoring Devices Market market is studied from 2018 - 2026.

The Asia-Pacific Cardiac Arrhythmia Monitoring Devices Market is growing at a CAGR of 4.5% over the next 5 years.

Abbott Laboratories Inc, Biotronik, Medtronic PLC, GE Healthcare, Koninklijke Philips NV are the major companies operating in Asia-Pacific Cardiac Arrhythmia Monitoring Devices Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!